Gilead Gets Buy, Amgen Holds: Biopharma Calls Roil Markets
Wall Street resorts to fresh coverage on three large cap biopharma names as Jefferies flags Gilead and Amgen while JP...
Assess which market exposure—Total Market or SP 500—offers more durable performance for retirement spending and resilience.
28,477 articlesWall Street resorts to fresh coverage on three large cap biopharma names as Jefferies flags Gilead and Amgen while JP...
Investors are zooming in on InspireMD after its Q1 2026 earnings. This detailed look breaks down the numbers, the pro...
Six years after Bitcoin endured its COVID-era collapse, the market has staged a dramatic rebound. This piece examines...
Mega IPOs spark big bets and bigger headlines. This guide unpacks whether elon musk selling 'hopium' is fueling Space...
Palantir's chief technology officer raised alarms about U.S. weapon stock levels in a recent discussion, prompting re...
Berkshire Hathaway unveils a major acquisition for $8.5 billion, signaling Greg Abel’s first big, contrarian bet as t...
Ethereum surged about 8% over the past week, trading around $2,200 as traders weigh the next leg higher. On-chain sig...
An insider at Rackspace Technology recently disclosed a significant stock sale. This article explains what that means...
Carvana’s stock run looked extraordinary, up 4,300% in three years. But the strongest buy signal wasn’t the hype—it w...
As mortgage rates wobble and demand shifts, master planned communities are being judged on staying power rather than ...
Simone Biles and Jonathan Owens left their Texas custom home after a month, relocating to Indianapolis as Owens joins...
Energy Fuels stock is catching a strong bid as investors react to fresh progress in its rare-earths unit and a broade...